Advertisement
Advertisement
(FILES) This file photo taken on March 07, 2016 shows Russian tennis player Maria Sharapova speaking during a press conference in Los Angeles. Russian tennis star Maria Sharapova has been banned for two years after failing a drug test, the International Tennis Federation (ITF) announced on June 8, 2016. Sharapova tested positive for the controversial banned medication meldonium during January's Australian Open. / AFP PHOTO / ROBYN BECK

Maria Sharapova to learn of verdict on doping appeal by Tuesday

Russian tennis star has challenged an ITF-imposed two-year doping ban for taking meldonium

The verdict in Maria Sharapova’s appeal against a two-year doping ban will be announced on Tuesday.

The Court of Arbitration for Sport says it will issue the decision at 3pm local time.

Sharapova challenged an International Tennis Federation (ITF) ban imposed after she tested positive at the Australian Open for meldonium.

Maria Sharapova expects to learn the outcome of her appeal on Tuesday. Photo: Reuters

An ITF panel found that the Russian did not intend to cheat, but was at “very significant fault”.

Sharapova acknowledged taking meldonium before each match in Melbourne, claiming she was not aware it had been banned by the World Anti-Doping Agency.

Sharapova said she was prescribed the Latvian-made heart drug since 2006. Meldonium, also known as mildronate, is not approved for use in the United States where she lives.

Her ban expires in January 2018.

Post